| Page 91 | Kisaco Research
 

Humna Khan

Head of Procurement and Product Performance
Abbott Lyon

Humna Khan

Head of Procurement and Product Performance
Abbott Lyon

Humna Khan

Head of Procurement and Product Performance
Abbott Lyon
 

Sophie Robins

Technical Lead - Food Systems UK & Europe
Forum for the Future

Sophie Robins

Technical Lead - Food Systems UK & Europe
Forum for the Future

Sophie Robins

Technical Lead - Food Systems UK & Europe
Forum for the Future
 

Phil Harris

Chief Revenue Officer
Arva Intelligence

Senior executive with deep experience in environmental markets, capital markets, financial technology, blockchain, digital supply chains, and food traceability. Specializes in corporate development, revenue strategy, commercial growth, and scaling technology solutions across global industries, with a strong track record in sales leadership, partner engagement, and investor support.

Read full bio

Phil Harris

Chief Revenue Officer
Arva Intelligence

Phil Harris

Chief Revenue Officer
Arva Intelligence

Senior executive with deep experience in environmental markets, capital markets, financial technology, blockchain, digital supply chains, and food traceability. Specializes in corporate development, revenue strategy, commercial growth, and scaling technology solutions across global industries, with a strong track record in sales leadership, partner engagement, and investor support.

 

Ambar Arif

Director, Supply Chain Resilience
Mars

Ambar Arif

Director, Supply Chain Resilience
Mars

Ambar Arif

Director, Supply Chain Resilience
Mars
 

Kashif Patel

Global Strategic Buyer
Decathlon

Kashif Patel

Global Strategic Buyer
Decathlon

Kashif Patel

Global Strategic Buyer
Decathlon

This session brings together senior in-house patent litigators involved in some of the most influential recent pharma and biotech cases, to examine how life sciences litigation strategy is shifting and what in-house teams should be preparing for next.

  • Review key cases and court decisions from the past year, and what they reveal about where pharma and biotech patent litigation is evolving.
  • How PTAB procedural developments are changing risk assessment, sequencing, and settlement strategy.
  • Review venue selection within the US and consider when long-arm litigation can create leverage.

Author:

Jason Murata

VP, IP
Alvotech
... read more

Jason Murata

VP, IP
Alvotech

Author:

Petra Scamborova

Assistant General Counsel
Regeneron
... read more

Petra Scamborova

Assistant General Counsel
Regeneron

Author:

Rob Rodrigues

Partner
RNA Law
... read more

Rob Rodrigues

Partner
RNA Law

Author:

Eric Dittmann

Partner and Co-Chair, IP Practice
Paul Hastings
... read more

Eric Dittmann

Partner and Co-Chair, IP Practice
Paul Hastings

Author:

Niels Hölder

Partner
Carpmaels & Ransford
... read more

Niels Hölder

Partner
Carpmaels & Ransford

A concise review of recent US trade secret decisions that are shaping how courts assess reasonable measures, access, and remedies. This session brings together judges from key US jurisdictions to discuss the evolving expectations and outcomes from the most influential recent trade secret cases.

Author:

Adam Gershenson

Partner
Weil
... read more

Adam Gershenson

Partner
Weil

Author:

Cathy Bissoon

Honorable Judge
U.S. District Court, Western District Of Pennsylvania
... read more

Cathy Bissoon

Honorable Judge
U.S. District Court, Western District Of Pennsylvania

Author:

Christopher K. Barry-Smith

Honorable Judge
State of Massachusetts Superior Court
... read more

Christopher K. Barry-Smith

Honorable Judge
State of Massachusetts Superior Court

Author:

William Young

Honorable Judge
U.S. District Court, District of Massachusetts
... read more

William Young

Honorable Judge
U.S. District Court, District of Massachusetts

Author:

MaryJoan McNamara

Administrative Law Judge
US ITC
... read more

MaryJoan McNamara

Administrative Law Judge
US ITC

Author:

Sophie Wang

Co-Head – IP Litigation
Choate Hall & Stewart LLP

Sophie Wang is a Partner in Litigation and is Co-Head of the IP Litigation practice. She is a first-chair trial lawyer who represents biotech, pharmaceutical, and technology companies in complex and high stakes intellectual property and commercial disputes across the country. Sophie is a go-to resource for clients in the life sciences industry, including for “bet-the-company” patent litigation (including Hatch-Waxman and biosimilar litigation), post-grant review (PGR) and inter partes review (IPR) proceedings before the United States Patent Trial and Appeal Board (PTAB), trade secrets litigation, and contract, licensing, and other commercial disputes. She also routinely advises clients on the management of their US and global patent and litigation strategies, including regularly consulting with counsel before the EPO and in the UK, Germany, and other foreign jurisdictions.

... read more

Sophie Wang

Co-Head – IP Litigation
Choate Hall & Stewart LLP

Sophie Wang is a Partner in Litigation and is Co-Head of the IP Litigation practice. She is a first-chair trial lawyer who represents biotech, pharmaceutical, and technology companies in complex and high stakes intellectual property and commercial disputes across the country. Sophie is a go-to resource for clients in the life sciences industry, including for “bet-the-company” patent litigation (including Hatch-Waxman and biosimilar litigation), post-grant review (PGR) and inter partes review (IPR) proceedings before the United States Patent Trial and Appeal Board (PTAB), trade secrets litigation, and contract, licensing, and other commercial disputes. She also routinely advises clients on the management of their US and global patent and litigation strategies, including regularly consulting with counsel before the EPO and in the UK, Germany, and other foreign jurisdictions.

Author:

Ryan Daniel

Associate General Counsel
Fresenius Kabi
... read more

Ryan Daniel

Associate General Counsel
Fresenius Kabi

Author:

Erin Bell

Lead Counsel, Global Data, Digital & Technology
Takeda Pharmaceutical
... read more

Erin Bell

Lead Counsel, Global Data, Digital & Technology
Takeda Pharmaceutical

Author:

Ken Corsello

US Trade Secrets Counsel / Patent Licensing Counsel
IBM Corporation

Ken Corsello is an IP Law Counsel at IBM.  He currently focuses on drafting and negotiating patent licenses and assignment agreements.  At IBM, he has worked on patent procurement, litigation, client counseling, product clearance, and IP transactional matters. 

Before joining IBM, Ken was a law clerk to Chief Judge Glenn Archer at the Federal Circuit; an Associate Solicitor in the USPTO; and in private practice at law firms in Washington, D.C.  He did his undergraduate work in Computer Science at SUNY Stony Brook, received his JD from the Catholic University, and obtained an LL.M. from George Washington University. 

Ken has been the chair of IPO’s Trade Secrets Committee since 2016.  His recent presentations on trade secret law include participating in a panel at the USPTO’s “Trending Issues in Trade Secrets: 2019” symposium and as a witness on behalf of IPO at the 2018 hearing on “Safeguarding Trade Secrets in the United States” held by the U.S. House Committee on the Judiciary, Subcommittee on Courts, Intellectual Property, and the Internet. 

... read more

Ken Corsello

US Trade Secrets Counsel / Patent Licensing Counsel
IBM Corporation

Ken Corsello is an IP Law Counsel at IBM.  He currently focuses on drafting and negotiating patent licenses and assignment agreements.  At IBM, he has worked on patent procurement, litigation, client counseling, product clearance, and IP transactional matters. 

Before joining IBM, Ken was a law clerk to Chief Judge Glenn Archer at the Federal Circuit; an Associate Solicitor in the USPTO; and in private practice at law firms in Washington, D.C.  He did his undergraduate work in Computer Science at SUNY Stony Brook, received his JD from the Catholic University, and obtained an LL.M. from George Washington University. 

Ken has been the chair of IPO’s Trade Secrets Committee since 2016.  His recent presentations on trade secret law include participating in a panel at the USPTO’s “Trending Issues in Trade Secrets: 2019” symposium and as a witness on behalf of IPO at the 2018 hearing on “Safeguarding Trade Secrets in the United States” held by the U.S. House Committee on the Judiciary, Subcommittee on Courts, Intellectual Property, and the Internet. 

Author:

Barbara Fiacco

Partner, Co-Chair, Patent & Trade Secrets Litigation Practice and Intellectual Property Department
Foley Hoag LLP
... read more

Barbara Fiacco

Partner, Co-Chair, Patent & Trade Secrets Litigation Practice and Intellectual Property Department
Foley Hoag LLP